<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Patient Health Record</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Michael Kwiatkowski</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">February 16, 1938 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>10961 Desert Long Drive Spc 309<br/>Calimesa, CA 92320, US<br/><br/>Primary Home Phone:  760-217-7902<br/>Email:  knoller56@gmail.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">13634 2.16.840.1.113883.4.391.334291<br/>13634 2.16.840.1.113883.4.391.334291.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">61a367f2-77d6-4a34-9b62-70eb97989866 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">February 18, 2025, 11:56:20, PST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Justin Tuot</td></tr><tr><td class="td_header_role_value internal_format">845 N Highland Springs Road<br/>Suite 102<br/>Beaumont, CA 92223-5789, US<br/><br/>Tel:  909-850-4211<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Vinh Le</td></tr><tr><td class="td_header_role_value internal_format">845 N Highland Springs Road<br/>Suite 102<br/>Beaumont, CA 92223-5789, US<br/><br/>Tel:  909-850-4211<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">chris kwiatkowski<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Michael Kwiatkowski<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  760-217-7902<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">CAMG Beaumont</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">845 N Highland Springs Road<br/>Suite 102<br/>Beaumont, CA 92223-5789, US<br/><br/>Tel:  909-850-4211<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">BASIC METABOLIC PANEL (10165)</span><br/>Reviewed date:12/31/2024 09:59:11 PM<br/>Interpretation:labs were normal/reassuring.<br/>Performing Lab:EN, Quest Diagnostics-West Hills
8401 Fallbrook Ave, West Hills
CA
91304-3226 Thomas J McDonald<br/>Notes/Report:<br/>NON-FASTING<br/>FASTING:YES<br/>FASTING: YES</td></tr><tr><td ID="result1_attr1">GLUCOSE</td><td>100</td><td>65-99 mg/dL</td><td ID="result1_attr1_notes"><p/><p>           Fasting reference interval</p><p>For someone without known diabetes, a glucose value</p><p>between 100 and 125 mg/dL is consistent with</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p></td></tr><tr><td ID="result1_attr2">UREA NITROGEN (BUN)</td><td>24</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result1_attr3">CREATININE</td><td>0.87</td><td>0.70-1.22 mg/dL</td><td/></tr><tr><td ID="result1_attr4">EGFR</td><td>84</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result1_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result1_attr5_notes"><p>   Not Reported: BUN and Creatinine are within</p><p>   reference range.</p></td></tr><tr><td ID="result1_attr6">SODIUM</td><td>139</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result1_attr7">POTASSIUM</td><td>4.2</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result1_attr8">CHLORIDE</td><td>100</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result1_attr9">CARBON DIOXIDE</td><td>32</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result1_attr10">CALCIUM</td><td>9.6</td><td>8.6-10.3 mg/dL</td><td/></tr><tr><td colspan="4"><span class="content_span">X ray : Spines, lumbar complete</span><br/>Reviewed date:12/23/2024 10:04:36 AM<br/>Interpretation:Abnl (no f/u needed)<br/>Performing Lab:<br/>Notes/Report:<br/>Abnl (no f/u needed)</td></tr><tr><td colspan="4"><span class="content_span">Urinalysis, Complete-003772</span><br/>Reviewed date:02/02/2025 08:52:56 PM<br/>Interpretation:labs were normal/reassuring.<br/>Performing Lab:Labcorp Phoenix, 5005 S 40th Street Ste 1200, Phoenix, Phone - 8007889743, Director - MDCollum<br/>Notes/Report:<br/>Clinical Information:SRC:UR<br/>Clinical Information:SRC:UR</td></tr><tr><td ID="result3_attr1">Specific Gravity</td><td>1.014</td><td>1.005-1.030</td><td/></tr><tr><td ID="result3_attr2">pH</td><td>8.0</td><td>5.0-7.5</td><td/></tr><tr><td ID="result3_attr3">Urine-Color</td><td>Yellow</td><td>Yellow</td><td/></tr><tr><td ID="result3_attr4">Appearance</td><td>Clear</td><td>Clear</td><td/></tr><tr><td ID="result3_attr5">WBC Esterase</td><td>Negative</td><td>Negative</td><td/></tr><tr><td ID="result3_attr6">Protein</td><td>Negative</td><td>Negative/Trace</td><td/></tr><tr><td ID="result3_attr7">Glucose</td><td>Negative</td><td>Negative</td><td/></tr><tr><td ID="result3_attr8">Ketones</td><td>Negative</td><td>Negative</td><td/></tr><tr><td ID="result3_attr9">Occult Blood</td><td>Negative</td><td>Negative</td><td/></tr><tr><td ID="result3_attr10">Bilirubin</td><td>Negative</td><td>Negative</td><td/></tr><tr><td ID="result3_attr11">Urobilinogen,Semi-Qn</td><td>0.2</td><td>0.2-1.0 mg/dL</td><td/></tr><tr><td ID="result3_attr12">Nitrite, Urine</td><td>Negative</td><td>Negative</td><td/></tr><tr><td ID="result3_attr13">Microscopic Examination</td><td/><td/><td ID="result3_attr13_notes">Microscopic follows if indicated.</td></tr><tr><td ID="result3_attr14">Microscopic Examination</td><td>See below:</td><td/><td ID="result3_attr14_notes">Microscopic was indicated and was performed.</td></tr><tr><td ID="result3_attr15">WBC</td><td>0-5</td><td>0 -  5 /hpf</td><td/></tr><tr><td ID="result3_attr16">RBC</td><td>None seen</td><td>0 -  2 /hpf</td><td/></tr><tr><td ID="result3_attr17">Epithelial Cells (non renal)</td><td>None seen</td><td>0 - 10 /hpf</td><td/></tr><tr><td ID="result3_attr18">Casts</td><td>None seen</td><td>None seen /lpf</td><td/></tr><tr><td ID="result3_attr19">Bacteria</td><td>None seen</td><td>None seen/Few</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC With Differential/Platelet-005009</span><br/>Reviewed date:02/02/2025 08:52:56 PM<br/>Interpretation:labs were normal/reassuring.<br/>Performing Lab:Labcorp Phoenix, 5005 S 40th Street Ste 1200, Phoenix, Phone - 8007889743, Director - MDCollum<br/>Notes/Report:<br/>Clinical Information:SRC:UR</td></tr><tr><td ID="result4_attr1">WBC</td><td>6.8</td><td>3.4-10.8 x10E3/uL</td><td/></tr><tr><td ID="result4_attr2">RBC</td><td>4.30</td><td>4.14-5.80 x10E6/uL</td><td/></tr><tr><td ID="result4_attr3">Hemoglobin</td><td>13.6</td><td>13.0-17.7 g/dL</td><td/></tr><tr><td ID="result4_attr4">Hematocrit</td><td>39.5</td><td>37.5-51.0 %</td><td/></tr><tr><td ID="result4_attr5">MCV</td><td>92</td><td>79-97 fL</td><td/></tr><tr><td ID="result4_attr6">MCH</td><td>31.6</td><td>26.6-33.0 pg</td><td/></tr><tr><td ID="result4_attr7">MCHC</td><td>34.4</td><td>31.5-35.7 g/dL</td><td/></tr><tr><td ID="result4_attr8">RDW</td><td>13.2</td><td>11.6-15.4 %</td><td/></tr><tr><td ID="result4_attr9">Platelets</td><td>253</td><td>150-450 x10E3/uL</td><td/></tr><tr><td ID="result4_attr10">Neutrophils</td><td>71</td><td>Not Estab. %</td><td/></tr><tr><td ID="result4_attr11">Lymphs</td><td>16</td><td>Not Estab. %</td><td/></tr><tr><td ID="result4_attr12">Monocytes</td><td>8</td><td>Not Estab. %</td><td/></tr><tr><td ID="result4_attr13">Eos</td><td>4</td><td>Not Estab. %</td><td/></tr><tr><td ID="result4_attr14">Basos</td><td>1</td><td>Not Estab. %</td><td/></tr><tr><td ID="result4_attr15">Neutrophils (Absolute)</td><td>4.8</td><td>1.4-7.0 x10E3/uL</td><td/></tr><tr><td ID="result4_attr16">Lymphs (Absolute)</td><td>1.1</td><td>0.7-3.1 x10E3/uL</td><td/></tr><tr><td ID="result4_attr17">Monocytes(Absolute)</td><td>0.6</td><td>0.1-0.9 x10E3/uL</td><td/></tr><tr><td ID="result4_attr18">Eos (Absolute)</td><td>0.2</td><td>0.0-0.4 x10E3/uL</td><td/></tr><tr><td ID="result4_attr19">Baso (Absolute)</td><td>0.1</td><td>0.0-0.2 x10E3/uL</td><td/></tr><tr><td ID="result4_attr20">Immature Granulocytes</td><td>0</td><td>Not Estab. %</td><td/></tr><tr><td ID="result4_attr21">Immature Grans (Abs)</td><td>0.0</td><td>0.0-0.1 x10E3/uL</td><td/></tr><tr><td colspan="4"><span class="content_span">Urine Culture, Routine-008847</span><br/>Reviewed date:02/02/2025 08:52:56 PM<br/>Interpretation:labs were normal/reassuring.<br/>Performing Lab:Labcorp Phoenix, 5005 S 40th Street Ste 1200, Phoenix, Phone - 8007889743, Director - MDCollum<br/>Notes/Report:<br/>Clinical Information:SRC:UR<br/>Clinical Information:SRC:UR</td></tr><tr><td ID="result5_attr1">Urine Culture, Routine</td><td>Final report</td><td/><td/></tr><tr><td ID="result5_attr2">Result 1</td><td>No growth</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">Basic Metabolic Panel (7)-303758</span><br/>Reviewed date:02/02/2025 08:52:56 PM<br/>Interpretation:Abnl (no f/u needed)<br/>Performing Lab:Labcorp Phoenix, 5005 S 40th Street Ste 1200, Phoenix, Phone - 8007889743, Director - MDCollum<br/>Notes/Report:<br/>Clinical Information:SRC:UR</td></tr><tr><td ID="result6_attr1">Glucose</td><td>109</td><td>70-99 mg/dL</td><td/></tr><tr><td ID="result6_attr2">BUN</td><td>16</td><td>8-27 mg/dL</td><td/></tr><tr><td ID="result6_attr3">Creatinine</td><td>0.89</td><td>0.76-1.27 mg/dL</td><td/></tr><tr><td ID="result6_attr4">eGFR</td><td>83</td><td>&gt;59 mL/min/1.73</td><td/></tr><tr><td ID="result6_attr5">BUN/Creatinine Ratio</td><td>18</td><td>10-24</td><td/></tr><tr><td ID="result6_attr6">Sodium</td><td>141</td><td>134-144 mmol/L</td><td/></tr><tr><td ID="result6_attr7">Potassium</td><td>3.9</td><td>3.5-5.2 mmol/L</td><td/></tr><tr><td ID="result6_attr8">Chloride</td><td>102</td><td>96-106 mmol/L</td><td/></tr><tr><td ID="result6_attr9">Carbon Dioxide, Total</td><td>27</td><td>20-29 mmol/L</td><td/></tr><tr><td colspan="4"><span class="content_span">Hemoglobin A1c-001453</span><br/>Reviewed date:02/07/2025 08:18:22 AM<br/>Interpretation:prediabetes<br/>Performing Lab:Labcorp Phoenix, 5005 S 40th Street Ste 1200, Phoenix, Phone - 8007889743, Director - MDCollum<br/>Notes/Report:<br/>Clinical Information:SRC:UR</td></tr><tr><td ID="result7_attr1">Hemoglobin A1c</td><td>5.7</td><td>4.8-5.6 %</td><td ID="result7_attr1_notes"><p>                                                       .</p><p>         Prediabetes: 5.7 - 6.4</p><p>         Diabetes: &gt;6.4</p><p>         Glycemic control for adults with diabetes: &lt;7.0</p></td></tr><tr><td colspan="4"><span class="content_span">Urine Culture, Routine-008847</span><br/>Reviewed date:02/10/2025 08:52:41 AM<br/>Interpretation:labs were normal/reassuring.<br/>Performing Lab:Labcorp Phoenix, 5005 S 40th Street Ste 1200, Phoenix, Phone - 8007889743, Director - MDCollum<br/>Notes/Report:<br/>Clinical Information:SRC:UR<br/>Clinical Information:SRC:UR</td></tr><tr><td ID="result8_attr1">Urine Culture, Routine</td><td>Final report</td><td/><td/></tr><tr><td ID="result8_attr2">Result 1</td><td>No growth</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">PSA Total (Reflex To Free)-480772</span><br/>Reviewed date:02/07/2025 08:18:22 AM<br/>Interpretation:labs were normal/reassuring.<br/>Performing Lab:Labcorp Phoenix, 5005 S 40th Street Ste 1200, Phoenix, Phone - 8007889743, Director - MDCollum<br/>Notes/Report:<br/>Clinical Information:SRC:UR</td></tr><tr><td ID="result9_attr1">Prostate Specific Ag</td><td>3.7</td><td>0.0-4.0 ng/mL</td><td ID="result9_attr1_notes"><p>Roche ECLIA methodology.</p><p>                                                                     .</p><p>According to the American Urological Association, Serum PSA should</p><p>decrease and remain at undetectable levels after radical</p><p>prostatectomy. The AUA defines biochemical recurrence as an initial</p><p>PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory</p><p>PSA value 0.2 ng/mL or greater.</p><p>Values obtained with different assay methods or kits cannot be used</p><p>interchangeably. Results cannot be interpreted as absolute evidence</p><p>of the presence or absence of malignant disease.</p></td></tr><tr><td ID="result9_attr2">Reflex Criteria</td><td/><td/><td ID="result9_attr2_notes"><p>The percent free PSA is performed on a reflex basis only when the</p><p>total PSA is between 4.0 and 10.0 ng/mL.</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Depression, worsening family stressors. Would benefit from therapy.</td></tr><tr><th>Diagnosis 1</th><td>Depression, major, recurrent, moderate (F33.1)</td></tr><tr><th>Referral Organization</th><td>CAMG Beaumont</td></tr><tr><th>Referring Provider First Name</th><td>Justin</td></tr><tr><th>Referring Provider Last Name</th><td>Tuot</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider Specialty</th><td>Psychologist</td></tr><tr><th>General Notes</th><td>Tuot,Justin P 12/10/2024 02:13:18 PM &gt;  Worsening stress at home, would benefit from therapy services., Ocampo, Ashley 12/12/2024 08:53:54 AM &gt;Referral Request ID: 20241212740376000007, Date Requested: 12/12/2024 08:53:13, Status: REQUESTED, Ocampo, Ashley 12/18/2024 08:23:55 AM &gt;Referral Request ID: 20241212740376000007, Date Requested: 12/12/2024 08:53:13, Status: APPROVED, Inland Psychiatric Medical Group, 34675 Yucaipa Blvd #108, Yucaipa, CA 92399-4155, Phone: (909) 793-9596</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Ingrown toenails</td></tr><tr><th>Diagnosis 1</th><td>Ingrown toenail of both feet (L60.0)</td></tr><tr><th>Referral Organization</th><td>CAMG Beaumont</td></tr><tr><th>Referring Provider First Name</th><td>Justin</td></tr><tr><th>Referring Provider Last Name</th><td>Tuot</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider Specialty</th><td>Podiatry</td></tr><tr><th>General Notes</th><td>Ocampo MA, Ashley 12/23/2024 08:03:58 AM &gt;Referral Request ID: 20241223740376000007, Date Requested: 12/23/2024 08:02:48, Status: APPROVED, Arrowhead Orthopaedics - Beaumont, 845 N Highland Springs Ave #101, Beaumont, CA 92223-5789, 909-557-1600</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>12/20/2024</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Eliquis 2.5 MG</td><td ID="instruction1">1 tablet Oral twice a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">cloNIDine HCl 0.3 MG</td><td ID="instruction2">1 tablet Oral twice a day for 100 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Spiriva Respimat 1.25 MCG/ACT</td><td ID="instruction3">2 puffs Inhalation Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">FLUoxetine HCl 40 MG</td><td ID="instruction4">1 capsule Orally Once a day for 90 days</td><td/><td>12/10/2024</td><td/><td>Active</td></tr><tr><td ID="medication5">Mometasone Furoate 50 MCG/ACT</td><td ID="instruction5">SPRAY 1 SPRAY INTO EACH NOSTRIL DAILY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">FLUoxetine HCl 20 MG</td><td ID="instruction6">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Losartan Potassium 100 MG</td><td ID="instruction7">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">hydroCHLOROthiazide 25 MG</td><td ID="instruction8">1 tablet in the morning Orally Once a day for 100 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Lovastatin 20 MG</td><td ID="instruction9">1 tablet with the evening meal Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div>No Information</div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Tobacco Control (Standard)</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>Nonsmoker</td><td/></tr></tbody></table><span class="content_span">AUDIT-C (Standard)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Adrenocortical hypofunction following procedure (disorder) (721290005)</td><td ID="Problem1">Postprocedural adrenocortical (-medullary) hypofunction (E89.6)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems1notes">No indication to recheck hormone-based labs in setting of controlled HTN. Consider rechecking adreno-cortical labs at a later time.</td></tr><tr><td>Problem</td><td>Dilatation of aorta (26660001)</td><td ID="Problem2">Thoracic aortic ectasia (I77.810)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems2notes"><p>Aortic abnormalities noted on prior imaging.</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td></tr><tr><td>Problem</td><td>Longstanding persistent atrial fibrillation (706923002)</td><td ID="Problem3">Longstanding persistent atrial fibrillation (I48.11)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems3notes">Previous heart monitoring with abnormal rhythm. Rate controlled on current medications. Patient is on anticoagulation without any past or current evidence of bleeding. Discussed that short bouts of tachycardia/a-fib will be monitored. Should document the times and will consider medication adjustments if they are becoming more frequent or longer lasting.ER precautions for pulse over 120 sustained over 24 hours and/or chest pain, syncope, or other concerning symptoms.</td></tr><tr><td>Problem</td><td>59621000</td><td ID="Problem4">Essential hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Moderate recurrent major depression (18818009)</td><td ID="Problem5">Depression, major, recurrent, moderate (F33.1)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems5notes">Denies SI, HI, AVH. No personal history of panic attacks, PTSD or manic episodes, significant fam history of bipolar, and no psychotic features.</td></tr><tr><td>Problem</td><td>Atherosclerosis of aorta (81817003)</td><td ID="Problem6">Atherosclerosis of aorta (HCC) (I70.0)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems6notes"><p>Aortic abnormalities noted on prior imaging.</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td></tr><tr><td>Problem</td><td>Hypercoagulable state (76612001)</td><td ID="Problem7">Secondary hypercoagulable state (D68.69)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems7notes"><p>In order to appropriately assess and treat the patient's overall risks associated with his atrial fibrillation, the following factors have been taken into consideration:</p><p>1. Is on anticoagulants.</p><p>2. Has CHADS2-VASC score &gt;0.</p><p>3. Has the following: HTN</p><p>4. Does not have history of CVA</p><p>This patient, therefore, has a hypercoagulable state secondary to atrial fibrillation with a moderate severity level. In order to provide continuity of care through all clinicians, this diagnosis (D68.69) has been added to the problem list and is reflected in the patient's management.</p></td></tr><tr><td>Problem</td><td>Stricture of artery (68109007)</td><td ID="Problem8">Tortuous aorta (CMS/HCC) (HCC) (I77.1)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems8notes"><p>Aortic abnormalities noted on prior imaging.</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td></tr><tr><td>Problem</td><td/><td ID="Problem9">Stage 3a chronic kidney disease (CMS/HCC) (HCC) (N18.31)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems9notes"><p>GFR within CKD range.</p><p>Continue to monitor labs regularly to evaluate for progression of kidney disease. Currently no signs of exacerbation. Blood pressure control addressed. Encouraged avoidance/limited use of nephrotoxic agents (e.g., NSAIDs).</p></td></tr><tr><td>Problem</td><td/><td ID="Problem10">Immunodeficiency due to conditions classified elsewhere (HCC) (D84.81)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems10notes"><p>Immunosuppressed due to emphysema (COPD)</p><p>Encouraged to take extra precaution regarding sick contacts. Reviewed vaccination history.</p></td></tr><tr><td>Problem</td><td>Emphysema of lung (87433001)</td><td ID="Problem11">Emphysema of lung (J43.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems11notes"><p>Prior abnormal PFT</p><p>Improved</p><p>Currently denies worsening cough, mucus production, SOB, fatigue</p><p>Continue current treatment regimen</p></td></tr><tr><td>Problem</td><td>Pulmonary hypertension (disorder) (70995007)</td><td ID="Problem12">Pulmonary hypertension (HCC) (I27.20)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems12notes"><p>Prior echocardiogram with RVSP &gt;30mm Hg</p><p>Stable, maintain good blood pressure control, monitor for acute cardiopulmonary symptoms.</p></td></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>53 /min</td><td>02/04/2025</td><td ID="vital1notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr><tr><th ID="vital2">Height-cm</th><td>180.34 cm</td><td>02/04/2025</td><td ID="vital2notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr><tr><th ID="vital3">Oximetry</th><td>95 %</td><td>02/04/2025</td><td ID="vital3notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr><tr><th ID="vital4">Blood pressure diastolic</th><td>67 mm Hg</td><td>02/04/2025</td><td ID="vital4notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr><tr><th ID="vital5">Weight-kg</th><td>86.18 kg</td><td>02/04/2025</td><td ID="vital5notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr><tr><th ID="vital6">Height</th><td>71 in</td><td>02/04/2025</td><td ID="vital6notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr><tr><th ID="vital7">Blood pressure systolic</th><td>106 mm Hg</td><td>02/04/2025</td><td ID="vital7notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr><tr><th ID="vital8">Weight</th><td>190.0lb lbs</td><td>02/04/2025</td><td ID="vital8notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr><tr><th ID="vital9">BMI</th><td>26.5 kg/m2</td><td>02/04/2025</td><td ID="vital9notes">Ocampo MA, Ashley 02/04/2025 08:20:03 AM &gt;</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>CAMG Beaumont</td><td>845 N Highland Springs Road Suite 102 Beaumont, CA 92223-5789</td><td>12/10/2024</td><td>Justin Tuot</td><td>Postprocedural adrenocortical (-medullary) hypofunction E89.6 ; Pulmonary hypertension (HCC) I27.20 ; Thoracic aortic ectasia I77.810 ; Immunodeficiency due to conditions classified elsewhere (HCC) D84.81 ; Longstanding persistent atrial fibrillation I48.11 ; Secondary hypercoagulable state D68.69 ; Atherosclerosis of aorta (HCC) I70.0 ; Tortuous aorta (CMS/HCC) (HCC) I77.1 ; Stage 3a chronic kidney disease (CMS/HCC) (HCC) N18.31 ; Depression, major, recurrent, moderate F33.1 ; Emphysema of lung J43.9 and Nasal obstruction J34.89</td></tr><tr><td>CAMG Beaumont</td><td>845 N Highland Springs Road Suite 102 Beaumont, CA 92223-5789</td><td>12/20/2024</td><td>Justin Tuot</td><td>Ingrown toenail of both feet L60.0 ; Medicare annual wellness visit, subsequent Z00.00 ; Cervicalgia M54.2 ; Other chronic pain G89.29 ; Low back pain, unspecified M54.50 ; Hypokalemia E87.6 and Essential hypertension I10</td></tr><tr><td>CAMG Beaumont</td><td>845 N Highland Springs Road Suite 102 Beaumont, CA 92223-5789</td><td>01/02/2025</td><td>Vinh Le</td><td>Essential hypertension I10</td></tr><tr><td>CAMG Beaumont</td><td>845 N Highland Springs Road Suite 102 Beaumont, CA 92223-5789</td><td>01/21/2025</td><td>Justin Tuot</td><td>Hx of sepsis Z86.19 ; Hypokalemia E87.6 ; Pulmonary hypertension (HCC) I27.20 ; Thoracic aortic ectasia I77.810 ; Immunodeficiency due to conditions classified elsewhere (HCC) D84.81 ; Longstanding persistent atrial fibrillation I48.11 ; Secondary hypercoagulable state D68.69 ; Atherosclerosis of aorta (HCC) I70.0 ; Tortuous aorta (CMS/HCC) (HCC) I77.1 ; Stage 3a chronic kidney disease (CMS/HCC) (HCC) N18.31 ; Depression, major, recurrent, moderate F33.1 ; Emphysema of lung J43.9 and Postprocedural adrenocortical (-medullary) hypofunction E89.6</td></tr><tr><td>CAMG Beaumont</td><td>845 N Highland Springs Road Suite 102 Beaumont, CA 92223-5789</td><td>02/04/2025</td><td>Justin Tuot</td><td>Urinary frequency R35.0 and IFG (impaired fasting glucose) R73.01</td></tr><tr><td>CAMG Beaumont</td><td>845 N Highland Springs Road Suite 102 Beaumont, CA 92223-5789</td><td>12/10/2024</td><td>Justin Tuot</td><td/></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">12/10/2024</td><td>Postprocedural adrenocortical (-medullary) hypofunction (ICD-10 - E89.6)</td><td/><td>Stable, continue to monitor labs as needed.</td><td><p>Tuot, Justin P 12/10/2024 17:10:28 PM &gt; R-sided, due to adrenal tumor causing potassium-wasting. Operated at USC 2001.</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref2">12/10/2024</td><td>Pulmonary hypertension (HCC) (ICD-10 - I27.20)</td><td/><td><p>Echocardiogram with RVSP &gt;30mm Hg ( 01/25/2022 )</p><p>Stable, maintain good blood pressure control, monitor for acute cardiopulmonary symptoms.</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:31 PM &gt; Echo from 1/25/22 with RV sys pressure of 37 mmHg.</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref3">12/20/2024</td><td>Medicare annual wellness visit, subsequent (ICD-10 - Z00.00)</td><td/><td>Well Visit, Over 65: Care Instructions material was printed, Learning About Depression material was printed, Learning About Generalized Anxiety Disorder material was printed, Learning About Managing Anger material was printed, Preventing Falls: Care Instructions material was printed, How to Get Up Safely After a Fall: Care Instructions material was printed, Hearing Loss: Care Instructions material was printed, Frequent Urination: Care Instructions material was printed, Bladder Training: Care Instructions material was printed, Kegel Exercises: Care Instructions material was printed, Learning About Eating More Fruits and Vegetables material was printed, Advance Directives: Care Instructions material was printed, Advance Care Planning: Care Instructions material was printed, Learning About Living Wills material was printed, Learning About Medical Power of Attorney material was printed</td><td/><td/></tr><tr><td ID="ref4">12/20/2024</td><td>Ingrown toenail of both feet (ICD-10 - L60.0)</td><td/><td>Subtle curvature of the great toenails in bilateral great toes. No obvious erythematous changes. Given pt's symptoms, will go ahead and refer to podiatry. Recommended frequent warm water soaks, application of triple antibiotic ointment to surround nailbeds.</td><td/><td/></tr><tr><td ID="ref5">01/02/2025</td><td>Essential hypertension (ICD-10 - I10)</td><td/><td/><td/><td/></tr><tr><td ID="ref6">01/21/2025</td><td>Hypokalemia (ICD-10 - E87.6)</td><td>Recheck towards the end of the week.</td><td/><td/><td/></tr><tr><td ID="ref7">01/21/2025</td><td>Hx of sepsis (ICD-10 - Z86.19)</td><td>Sepsis without source, per review of San G labs. It appears that he is responding well to antibiotics, so will continue course. Recheck labs towards the end of the week.</td><td/><td/><td/></tr><tr><td ID="ref8">02/04/2025</td><td>IFG (impaired fasting glucose) (ICD-10 - R73.01)</td><td>Check A1c.</td><td/><td/><td/></tr><tr><td ID="ref9">02/04/2025</td><td>Urinary frequency (ICD-10 - R35.0)</td><td>POCT UA was reassuring. Will send out for culture. Possibly related to insomnia, so will have pt try OTC melatonin gummies. If PSA wnl, can consider flomax.</td><td/><td/><td/></tr><tr><td ID="ref10">01/21/2025</td><td>Pulmonary hypertension (HCC) (ICD-10 - I27.20)</td><td><p>Prior echocardiogram with RVSP &gt;30mm Hg</p><p>Stable, maintain good blood pressure control, monitor for acute cardiopulmonary symptoms.</p></td><td/><td>Tuot, Justin P 01/21/2025 17:14:18 PM &gt; Echo from 1/25/22 with RV sys pressure of 37 mmHg. (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref11">12/20/2024</td><td>Cervicalgia (ICD-10 - M54.2)</td><td/><td>Ordering XR</td><td/><td/></tr><tr><td ID="ref12">12/10/2024</td><td>Thoracic aortic ectasia (ICD-10 - I77.810)</td><td/><td><p>Aortic abnormalities noted on prior CT .</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:33 PM &gt; CT chest from 7/7/21</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref13">12/10/2024</td><td>Immunodeficiency due to conditions classified elsewhere (HCC) (ICD-10 - D84.81)</td><td/><td><p>Immunosuppressed due to COPD</p><p>Encouraged to take extra precaution regarding sick contacts. Reviewed vaccination history.</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:35 PM &gt; Secondary to Emphysema</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref14">01/21/2025</td><td>Thoracic aortic ectasia (ICD-10 - I77.810)</td><td><p>Aortic abnormalities noted on prior imaging.</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td><td/><td>Tuot, Justin P 01/21/2025 17:14:19 PM &gt; CT chest from 7/7/21 (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref15">12/20/2024</td><td>Other chronic pain (ICD-10 - G89.29)</td><td/><td/><td/><td/></tr><tr><td ID="ref16">12/20/2024</td><td>Low back pain, unspecified (ICD-10 - M54.50)</td><td/><td>Ordering XR</td><td/><td/></tr><tr><td ID="ref17">01/21/2025</td><td>Immunodeficiency due to conditions classified elsewhere (HCC) (ICD-10 - D84.81)</td><td><p>Immunosuppressed due to emphysema (COPD)</p><p>Encouraged to take extra precaution regarding sick contacts. Reviewed vaccination history.</p></td><td/><td>Tuot, Justin P 01/21/2025 17:14:21 PM &gt; Secondary to Emphysema (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref18">12/10/2024</td><td>Longstanding persistent atrial fibrillation (ICD-10 - I48.11)</td><td/><td>Previous heart monitoring with abnormal rhythm. Rate controlled on current medications. Patient is on anticoagulation without any past or current evidence of bleeding. Discussed that short bouts of tachycardia/a-fib will be monitored. Should document the times and will consider medication adjustments if they are becoming more frequent or longer lasting.ER precautions for pulse over 120 sustained over 24 hours and/or chest pain, syncope, or other concerning symptoms.</td><td><p>Tuot, Justin P 12/10/2024 17:10:38 PM &gt; (CMS/HCC) 9/23/20 Outside records: Radiant Primary Care. Page 9 frm 9/18/20 OV Rx: apixaban (ELIQUIS) 2.5 MG tablet</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref19">12/10/2024</td><td>Secondary hypercoagulable state (ICD-10 - D68.69)</td><td/><td><p>In order to appropriately assess and treat the patient's overall risks associated with his atrial fibrillation, the following factors have been taken into consideration:</p><p>1. He is on anticoagulants.</p><p>2. He has a CHADS2-VASC score &gt;0.</p><p>3. He has the following: HTN</p><p>4. He does not have history of CVA</p><p>This patient, therefore, has a hypercoagulable state secondary to atrial fibrillation with a high severity level. In order to provide continuity of care through all clinicians, this diagnosis (D68.69) has been added to his problem list and is reflected in his management.</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:41 PM &gt; Due to Afib, CHADS2-VASC score &gt;0 </p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref20">12/20/2024</td><td>Hypokalemia (ICD-10 - E87.6)</td><td/><td>Check BMP in the beginning of January.</td><td/><td/></tr><tr><td ID="ref21">01/21/2025</td><td>Longstanding persistent atrial fibrillation (ICD-10 - I48.11)</td><td>Previous heart monitoring with abnormal rhythm. Rate controlled on current medications. Patient is on anticoagulation without any past or current evidence of bleeding. Discussed that short bouts of tachycardia/a-fib will be monitored. Should document the times and will consider medication adjustments if they are becoming more frequent or longer lasting.ER precautions for pulse over 120 sustained over 24 hours and/or chest pain, syncope, or other concerning symptoms.</td><td/><td>Tuot, Justin P 01/21/2025 17:14:24 PM &gt; 9/23/20 Outside records: Radiant Primary Care. Page 9 frm 9/18/20 OV Rx: apixaban (ELIQUIS) 2.5 MG tablet (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref22">12/20/2024</td><td>Essential hypertension (ICD-10 - I10)</td><td/><td>Improved on recheck. No changes to meds. Will have him return for nurse visit in 10-14 days for recheck.</td><td/><td/></tr><tr><td ID="ref23">01/21/2025</td><td>Secondary hypercoagulable state (ICD-10 - D68.69)</td><td><p>In order to appropriately assess and treat the patient's overall risks associated with his atrial fibrillation, the following factors have been taken into consideration:</p><p>1. Is on anticoagulants.</p><p>2. Has CHADS2-VASC score &gt;0.</p><p>3. Has the following: HTN</p><p>4. Does not have history of CVA</p><p>This patient, therefore, has a hypercoagulable state secondary to atrial fibrillation with a moderate severity level. In order to provide continuity of care through all clinicians, this diagnosis (D68.69) has been added to the problem list and is reflected in the patient's management.</p></td><td/><td>Tuot, Justin P 01/21/2025 17:14:26 PM &gt; Due to Afib, CHADS2-VASC score &gt;0 (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref24">12/10/2024</td><td>Atherosclerosis of aorta (HCC) (ICD-10 - I70.0)</td><td/><td><p>Aortic abnormalities noted on prior CT .</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:44 PM &gt; 9/23/20 Outside records: Radiant Primary Care.</p><p>6/17/12 CT Abdmn</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref25">12/10/2024</td><td>Tortuous aorta (CMS/HCC) (HCC) (ICD-10 - I77.1)</td><td/><td><p>Aortic abnormalities noted on prior CT .</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:46 PM &gt; 9/23/20 Outside records: Radiant Primary Care-seen on CXR 11/1/16.</p><p>11/6/21 CXR</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref26">01/21/2025</td><td>Atherosclerosis of aorta (HCC) (ICD-10 - I70.0)</td><td><p>Aortic abnormalities noted on prior imaging.</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td><td/><td>Tuot, Justin P 01/21/2025 17:14:29 PM &gt; 9/23/20 Outside records: Radiant Primary Care. 6/17/12 CT Abdmn (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref27">01/21/2025</td><td>Tortuous aorta (CMS/HCC) (HCC) (ICD-10 - I77.1)</td><td><p>Aortic abnormalities noted on prior imaging.</p><p>The patient is asymptomatic and stable. Will continue to monitor blood pressure and lipids to reduce risk of further deterioration. Should continue cholesterol-lowering diet.</p></td><td/><td>Tuot, Justin P 01/21/2025 17:14:31 PM &gt; 9/23/20 Outside records: Radiant Primary Care-seen on CXR 11/1/16. 11/6/21 CXR (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref28">12/10/2024</td><td>Stage 3a chronic kidney disease (CMS/HCC) (HCC) (ICD-10 - N18.31)</td><td/><td><p>GFR within CKD range.</p><p>Continue to monitor labs regularly to evaluate for progression of kidney disease. Currently no signs of exacerbation. Blood pressure control addressed. Encouraged avoidance/limited use of nephrotoxic agents (e.g., NSAIDs).</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:48 PM &gt; GFR: 6/22/2022-58.</p><p>GFR: 3/23/2022-51</p><p>GFR: 11/29/2021-45</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref29">12/10/2024</td><td>Depression, major, recurrent, moderate (ICD-10 - F33.1)</td><td/><td><p>Denies SI, HI, AVH. No personal history of panic attacks, PTSD or manic episodes, significant fam hx of bipolar, and no psychotic features.</p><p>Worsening control of depression in setting of recent stressor. Will increase prozac to 40mg.</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:51 PM &gt; 9/23/20 Outside records: Radiant Primary Care</p><p>Rx: prozac 20mg qd</p><p>2/13/24 PHQ 9 score of 12, consistent with moderate depression, remains on fluoxetine 20 mg. The patient reports moderately troubling symptoms of depression on most days.</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref30">01/21/2025</td><td>Stage 3a chronic kidney disease (CMS/HCC) (HCC) (ICD-10 - N18.31)</td><td><p>GFR within CKD range.</p><p>Continue to monitor labs regularly to evaluate for progression of kidney disease. Currently no signs of exacerbation. Blood pressure control addressed. Encouraged avoidance/limited use of nephrotoxic agents (e.g., NSAIDs).</p></td><td/><td>Tuot, Justin P 01/21/2025 17:14:33 PM &gt; GFR: 6/22/2022-58. GFR: 3/23/2022-51 GFR: 11/29/2021-45 (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref31">01/21/2025</td><td>Depression, major, recurrent, moderate (ICD-10 - F33.1)</td><td>Denies SI, HI, AVH. No personal history of panic attacks, PTSD or manic episodes, significant fam history of bipolar, and no psychotic features.</td><td/><td>Tuot, Justin P 01/21/2025 17:14:35 PM &gt; - PHQ2 done on 12/20/24 (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref32">12/10/2024</td><td>Emphysema of lung (ICD-10 - J43.9)</td><td/><td><p>Stable</p><p>Currently denies worsening cough, SOB and fatigue</p><p>Continue on current treatment regimen</p></td><td><p>Tuot, Justin P 12/10/2024 17:10:54 PM &gt; 9/23/20 Outside records: Radiant Primary Care. Page 9 frm 9/18/20 OV. Rx: albuterol (ProAir HFA) 108 (90 Base) MCG/ACT inhaler, Tiotropium Bromide Monohydrate (Spiriva Respimat) 1.25 MCG/ACT aerosol solution</p><p> (Notes added from the To Do list)</p></td><td/></tr><tr><td ID="ref33">12/10/2024</td><td>Nasal obstruction (ICD-10 - J34.89)</td><td/><td>Mucus noted on exam. Will try nasonex spray for next 2 weeks.</td><td/><td/></tr><tr><td ID="ref34">01/21/2025</td><td>Emphysema of lung (ICD-10 - J43.9)</td><td><p>Prior abnormal PFT</p><p>Improved</p><p>Currently denies worsening cough, mucus production, SOB, fatigue</p><p>Continue current treatment regimen</p></td><td/><td>Tuot, Justin P 01/21/2025 17:14:37 PM &gt; 9/23/20 Outside records: Radiant Primary Care. Page 9 frm 9/18/20 OV. Rx: albuterol (ProAir HFA) 108 (90 Base) MCG/ACT inhaler, Tiotropium Bromide Monohydrate (Spiriva Respimat) 1.25 MCG/ACT aerosol solution (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref35">01/21/2025</td><td>Postprocedural adrenocortical (-medullary) hypofunction (ICD-10 - E89.6)</td><td>No indication to recheck hormone-based labs in setting of controlled HTN. Consider rechecking adreno-cortical labs at a later time.</td><td/><td>Tuot, Justin P 01/21/2025 17:14:39 PM &gt; R-sided, due to adrenal tumor causing potassium-wasting. Operated at USC 2001. (Notes added from the To Do list)</td><td/></tr><tr><td ID="ref36">12/20/2024</td><td>Other</td><td/><td/><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">X ray : Spines, cervical 4 views</td><td>12/20/2024</td></tr><tr><td ID="pendingTest2">Urine dipstick, point-of-care measurement</td><td>02/04/2025</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>HEALTHLY MED GRP SCAN</td><td>PO Box 4367 Orange, CA 92863</td><td/><td>31021636801</td><td/><td>Kwiatkowski, Michael</td><td>Self - patient is the insured</td><td>12/01/2024</td><td/></tr></tbody></table></div><br/><br/></body></html>